# A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of Nemiralisib

> **NCT03398421** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 20 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Nemiralisib
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT03398421
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-17
- **Primary completion:** 2018-03-12
- **Final completion:** 2018-03-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03398421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03398421, "A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of Nemiralisib". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03398421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*